Every investor likes to find a clear market signal, indicating the right stock to buy – and there are few signals clearer ...

May 05, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the publication of its health economics data for reconstruction of cutaneous wounds with ...

Organogenesis Holdings Inc.’s ORGO share price has dipped by 21.72%, which has investors questioning if this is right time to buy.

Tissues suitable for cytogenetic study include placental villi, chorion, amnion, skin, or internal organs such as liver, lung, kidney, or spleen. For early gestation, the entire abortus may be ...

Detailed price information for Biostem Technologies Inc (BSEM) from The Globe and Mail including charting and trades.

The company also recently announced that its proprietary amnion chorion allograft, known as BioRetain has been approved by the Institutional Review Board (IRB) for the treatment of venous leg ulcers.

Radical prostatectomy reduces mortality among men with clinically detected localized prostate cancer, but evidence from randomized trials with long-term follow-up is sparse. We randomly assigned ...

MiMedx Group Inc. reported its first-quarter earnings for 2025, meeting analyst expectations with an earnings per share (EPS) of $0.06. The company posted revenue of $88.2 million, slightly ...